{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigyoeytwpsf3x7mbedqo4m6ikhiniswlowy32qqvprmtgyzeuwdji",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mol4uta6d4f2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifyql5a4jramyakswlr6v7lvfr6vgwakxkcifrhtscnoakj3aboza"
    },
    "mimeType": "image/jpeg",
    "size": 175401
  },
  "path": "/news/2026-06-proteins-fueling-rare-childhood-leukemia.html",
  "publishedAt": "2026-06-18T10:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Indiana University School of Medicine cancer researchers have identified a potential way to use existing, accessible drugs to combat juvenile myelomonocytic leukemia (JMML) by targeting a specific inflammatory pathway. The findings, published in the journal Blood, open the door to more effective treatment options for this rare and aggressive childhood blood cancer, especially for high-risk pediatric patients who currently face limited options.",
  "title": "Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy"
}